BSE has notified trading members that Blue Blends (India) Ltd (Scrip Code: 502761) has fixed 17 April 2026 as the Record Date for implementing a Resolution Plan approved by the Hon’ble National Company Law Tribunal (NCLT), Mumbai Bench, and the Hon’ble National Company Law Appellate Tribunal (NCLAT), Principal Bench, New Delhi. The plan involves a reduction of equity share capital with differential treatment for promoters and public shareholders.

Key Points

• Record Date for capital reduction: 17 April 2026
• Settlement reference: DR-612/2026-2027
• All equity shares held by Promoters and Promoter Group will be fully cancelled and extinguished
• Public shareholders will hold a minimum of 5% of the Post Reduced Capital after completion of the Corporate Insolvency Resolution Process (CIRP) and allotment of new shares
• Trading in the equity shares of the company is currently under Suspension
• No dealings effective from 17 April 2026

Regulatory Changes

The capital reduction is being executed pursuant to a Resolution Plan under the Insolvency and Bankruptcy Code (IBC), sanctioned by both NCLT Mumbai Bench and NCLAT Principal Bench, New Delhi. This is a court-mandated corporate restructuring, not a voluntary corporate action.

Compliance Requirements

• Trading members are informed not to deal in the equity shares of Blue Blends (India) Ltd effective 17 April 2026
• Members must note the ongoing trading suspension in the scrip
• Depositories and registrars should process the share capital reduction as per the approved Resolution Plan on the record date

Important Dates

Impact Assessment

Promoters/Promoter Group: Complete loss of equity stake — all shares cancelled and extinguished with no compensation indicated under the Resolution Plan.

Public Shareholders: Existing public holdings will be extinguished as part of the CIRP process; however, public shareholders are guaranteed a minimum 5% stake in the post-reduced (restructured) capital through allotment of new shares.

Market Impact: The stock is already under trading suspension, limiting immediate market impact. The implementation of the NCLAT-approved Resolution Plan signals progression of the insolvency proceedings toward resolution. Investors holding the scrip face near-total dilution pending new share allotment under the Resolution Plan.